Rapalogix raises $20m for longevity skin health (opens in new tab)

Series A funding will expand Re-Q and advance a pipeline built on mTOR biology as longevity science seeks commercial traction. Rapalogix Health has raised $20 million in Series A financing to support the expansion of its longevity-focused skin health platform, as investors continue to back companies attempting to translate aging biology into products with clear […] The post appeared first on <a href="